WHO guidelines for the treatment of Neisseria gonorrhoeae

The objectives of these World Health Organization guidelines are to provide evidence-based guidance on treatment of infection with neisseria gonorrhoeae and support countries to update their national guidelines for treatment of gonococcal infection.


N.B. There is an urgent need to update treatment recommendations for gonococcal infections to respond to changing antimicrobial resistance (AMR) patterns of N. gonorrhoeae. High-level resistance to previously recommended quinolones is widespread and decreased susceptibility to the extended-spectrum (third-generation) cephalosporins, another recommended first-line treatment in the 2003 guidelines, is increasing and several countries have reported treatment failures.

(Content adapted from the WHO)